Cargando…
Indoleamine 2,3-dioxygenase mediates immune-independent human tumor cell resistance to olaparib, gamma radiation, and cisplatin
Indoleamine 2,3-dioxygenase-1 (IDO) is an immunosuppressive molecule expressed by most human tumors. IDO levels correlate with poor prognosis in cancer patients and IDO inhibitors are under investigation to enhance endogenous anticancer immunosurveillance. Little is known of immune-independent funct...
Autores principales: | Vareki, Saman Maleki, Rytelewski, Mateusz, Figueredo, Rene, Chen, Di, Ferguson, Peter J., Vincent, Mark, Min, Weiping, Zheng, Xiufen, Koropatnick, James |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058044/ https://www.ncbi.nlm.nih.gov/pubmed/24784564 |
Ejemplares similares
-
Inhibition of BRCA2 and Thymidylate Synthase Creates Multidrug Sensitive Tumor Cells via the Induction of Combined “Complementary Lethality”
por: Rytelewski, Mateusz, et al.
Publicado: (2013) -
Reciprocal positive selection for weakness - preventing olaparib resistance by inhibiting BRCA2
por: Rytelewski, Mateusz, et al.
Publicado: (2016) -
IDO Downregulation Induces Sensitivity to Pemetrexed, Gemcitabine, FK866, and Methoxyamine in Human Cancer Cells
por: Maleki Vareki, Saman, et al.
Publicado: (2015) -
siRNA knockdown of mitochondrial thymidine kinase 2 (TK2) sensitizes human tumor cells to gemcitabine
por: Di Cresce, Christine, et al.
Publicado: (2015) -
Suppression of Immunodominant Antitumor and Antiviral CD8(+) T Cell Responses by Indoleamine 2,3-Dioxygenase
por: Rytelewski, Mateusz, et al.
Publicado: (2014)